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Natural oriﬁce translumenal endoscopic surgery (N.O.T.E.S) is a technique that allows access to the
peritoneal cavity through natural oriﬁces (oral, rectal, vaginal, vesical) without passing through the
anterior abdominal wall. Rapid strides have been made in developing this technique, especially in animal
models. Majority of research work in this ﬁeld is originating from USA, while human clinical trials are
being reported from India and Southern America. Morbidly obese patients and ITU patients are two
target groups where N.O.T.E.S if implemented, will have the highest potential and bearing. With
increasing evidence of safe practice in human models, questions on indications and feasibility of practice
need to be addressed by rigorous research, strong evidence and collaboration between surgical centers
worldwide.
 2009 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
As surgery has evolved through generations, minimally invasive
surgery has gained signiﬁcance. With technological advances,
minimal invasive surgery has broken new grounds in the diagnosis
and treatment of surgical diseases. ‘‘No scar surgery’’ has always
fascinated patients and surgeons like, hence leading to the evolu-
tion of natural oriﬁce translumenal endoscopic surgery (N.O.T.E.S).
Conventional laparotomy has been the gold standard, but with
complications like wound infections, incisional hernias, adhesions,
post operative pain and delayed recovery paved the way for the
emergence of laparoscopic surgery.1,2
In the latter end of the 20th century, laparoscopic surgical
procedures have taken precedence over conventional laparotomy
as the complication rates are much lesser compared to open
surgery, but even they are not devoid of complications.3–5,7 Endo-
scopic procedures have a relatively low incidence of complications
(depending on the procedures) and advancement of these skills has
led to the development of N.O.T.E.S.6 N.O.T.E.S is a technique that
allows access to the peritoneal cavity through natural oriﬁces (oral,
rectal, vaginal or vesical) without passing through the anterior
abdominal wall and amalgamates the skills of endoscopy,toke on Trent, ST4 4BZ, UK.
kar).
ciates Ltd. Published by Elsevier Ltgastroenterology with minimally invasive and general surgery. This
has redeﬁned the surgical approach to the peritoneal cavity, espe-
cially for accessing organs like the appendix, gall bladder, liver,
spleen and fallopian tubes. With preliminary research into animal
models showing lesser complication rates compared to the lapa-
roscopic approach, it heralds a new uprising in the way surgery will
be carried out in the future, but whether this will happen, remains
to be seen.
The aim of this manuscript is to provide a brief review of the
existing literature with regards to N.O.T.E.S, speciﬁcally looking at
its advantages it may offer in morbidly obese and critically ill
surgical patients. The literature review was carried out using
MEDLINE and PUBMED databases using the terms: translumenal/
transvaginal/transgastric/transcolonic surgery, N.O.T.E.S, minimally
invasive surgery and endoscopic surgery. Articles that provided
a snapshot of the current procedures being performed in animal
and human models, with emphasis on the success achieved in
human populations were included in the review.2. History and evolution of N.O.T.E.S
Earliest evidence of N.O.T.E.S can be traced to 1901 when Dimitri
Oskarovich Ott performed endoscopic examination of the perito-
neal cavity through the vagina. The procedure then was termed
‘‘ventroscopy’’.8 In the late 1990s, many procedures employing
hybrid laparoscopic methods and transvaginal procedures were
published, but did not evolve owing to the lack of appropriated. All rights reserved.
Table 1
Successful N.O.T.E.S in animal models.
General surgical procedures Gynaecological procedures
 Adrenalectomy
 Appendicectomy
 Nephrectomy
 Cholecystectomy
 Spleenectomy
 Liver biopsies
 Ventral hernia
 Inguinal hernia
 Sleeve gastrectomy
 Gastro-jejunal anastomosis
 Peritoneoscopy
 Distal pancreatectomy
 Hysterectomy
 Fallopian tube clipping
 Oophrectomy
 Partial hysterectomy
Table 2
Successful N.O.T.E.S in humans.
Author Year Procedure Number of
patients
Palanivelu et al14,42 2009 TV cholecystectomy 6
2008 TV appendicectomy 1/6
Auyang et al52 2009 TG hybrid cholecystectomy 4
Vitale et al54 2009 TG drainage of pancreatic abcess 28
Zorro´n et al12,13,40 2008 TV peritoneoscopyþ liver,
diaphragm, ovary biopsy
1
2008 TV cholecystectomy 4
2007 TV cholecystectomy 1
Hazey et al55 2008 TG peritoneoscopy 10
Marks et al56 2007 PEG rescue, TG peritoneoscopy 1
Rao and Reddy43 2006 TG appendicectomy 1
TV¼ transvaginal; TG¼ transgastric.
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emerging success of laparoscopic procedures. The earliest mention
about N.O.T.E.S in the 21st century was by Kalloo et al who pub-
lished the ﬁndings about transgastric transperitoneal exploration
in a porcine model.9,10 Since then, much research has gone into
exploring the techniques and feasibility of N.O.T.E.S in animal
models, predominantly in porcine and swine models.
N.O.T.E.S in humans were also reported at the same time, with
reports of the ﬁrst human transgastric appendicectomy (by Rao
and Reddy) in a burn patient from India in 2004.43 Zorro´n et al
from Brazil published the ﬁrst case of transvaginal cholecystec-
tomy in December 2007 and recently, used transvaginal N.O.T.E.S
for cancer staging.12,13 Palanivelu et al from India have published
the feasibility of a hybrid approach for transvaginal cholecystec-
tomy, and have recently reported the ﬁrst case of transvaginal
appendicectomy.14,15 With cautious success demonstrated in
animal models, further research and development in instrumen-
tation could see these procedures being performed in humans.
3. Basic surgical technique of N.O.T.E.S (as demonstrated in
animal models)
3.1. Access to peritoneal cavity
Transgastric access to the peritoneal cavity remains the most
researched and published,16,18 while transvaginal, transvesical and
transcolonic access are being explored.17,19,20 To reduce the risk of
infection following lumenal puncture to gain access, possible
solutions like gastric lavagewith antiseptic solution, administration
of prophylactic antibiotics and use of sterile instruments have been
advocated.21,22 Transvaginal approach seems superior to the other
approaches as closure and leakage are not seen to be a major
problem, as established by various gynaecological procedures. This
approach has therefore been in the forefront in developing
N.O.T.E.S in human models.4,14 Feasibility of achieving adequate
closure with minimal complications will dictate the ideal access
route in the future.
3.2. Instrumentation
Endoscopes which have demonstrated ﬂexibility in their design
and use have been traditionally used for intralumenal applications
in humans. This has paved the way for its use in animal and human
models for application of N.O.T.E.S, and has been met with relative
success.41 Newer endoscopic instruments with increased retro-
ﬂexion and multiple lumens are being developed to accelerate and
supplement the success of N.O.T.E.S. As ﬂexible instruments are not
precise, some rigidity is needed for safe dissection as well as
retraction. Presently, discussion and research in literature revolve
around stabilization devices vs. transabdominal retractors, single
umbilical port for camera/retractor vs. transumbilical ﬂexible
endoscopic surgery (TUFES). Though adequate exposure and
retraction remain an issue with the single oriﬁce approach, recent
reports favour a combined two oriﬁce approach41 or hybrid
approach with laparoscopy,15 which may very well be the way
forward in implementing N.O.T.E.S.
3.3. Procedure
Viscus perforation for introducing the endoscope into the
peritoneal cavity is generally achieved by needle knife cautery
followed by balloon dilation, while other techniques like pull-type
sphincterotome have also been described.24,25 A transgastric
approach offers better visualisation of pelvic organs, while
a transcolonic and transvaginal approach visualises the upperabdominal organs better. Submucosal endoscopy with mucosal ﬂap
(SEMF) technique is one of the novel techniques described which
hypothesises on the creation of a submucosal working space that
minimizes contamination of the peritoneal cavity and aids closure
with a mucosal ﬂap.23 Standard compressors through the endo-
scope and standard laparoscopic insufﬂators have been described
for intraperitoneal insufﬂations with carbon-di-oxide or air,24 but
questions still remain about their reliability. McGee et al have
demonstrated in a porcinemodel that monitoring pressure through
an endoscope is reliable and predictive of the true intra abdominal
pressure, which can be improved upon and incorporated for the
future.26
The surgical procedures that have been performed in animal
models include appendicectomy, nephrectomy, cholecystectomy,
spleenectomy etc to gynaecological procedures like hysterectomy,
fallopian tube clipping, oophrectomy etc, which have been sum-
marised in Table 1.5,14,27–32,50,51 N.O.T.E.S procedures successfully
carried out in humans include appendicectomy, cholecystectomy,
peritoneoscopy and intra abdominal biopsies etc, and a summary of
the procedures that have been performed in the human population
from different authors is tabulated in Table 2.
3.4. Closure
Closure of the viscerotomy has been achieved though various
devices including endoscopic stapler devices which have shown
promise in animal models, and are continually being improved
upon. Other closure devices mentioned include the Stringer device
(novel endoscopic and incision and closure device), the Eagle Claw,
endoclips etc, which have shownpromising adequate closure of the
viscerotomy hole.24,32–35 Though these devices have shown
Table 3
Challenges for implementation of N.O.T.E.S in humans.
Challenges to overcome
Technique and instrument related:
 Ideal access to peritoneal cavity
 Ideal stapling and anastomotic devices
 Ideal insufﬂation devices
 Ideal intra abdominal pressure monitoring device
 Spatial orientation
 Flexible vs. stiff instruments
Procedure related:
 Infection and leaks
 Physiological untoward events
 Dealing with intra-operative haemorrhage and intraperitoneal complications
 Compression syndromes
 Hybrid vs. laparoscopic conversion
Personnel related:
 Training
 Surgeon vs. gastroenterologist
 Steep learning curve
 Multidisciplinary approach
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implementation in humans.
4. Potential advantages of N.O.T.E.S
Considering N.O.T.E.S employs a non-abdominal approach, the
potential advantages include reduced post operative pain along
with the reduced risk of surgical wound related complications like
wound infections and incisional hernia.14,36 Supporting this, in his
ﬁrst preliminary application of N.O.T.E.S in human models, Zorro´n
et al36 showed that there was a decreased need for post operative
analgesia along with reduced hospital stay in his patients following
transvaginal cholecystectomy. Palanivelu et al14 have also pub-
lished results showing enhanced post operative recovery and
minimal complications in patients following transvaginal appen-
dicectomies. Both these papers have demonstrated that N.O.T.E.S is
feasible, and a combined hybrid approach can be employed for
difﬁcult N.O.T.E.S.
As N.O.T.E.S is not a standardised procedure, the physiologic
response has been difﬁcult to quantify. It can be hypothesised that
a less invasive approach would lead to a decreased inﬂammatory
response contributing to an overall decrease in the ‘‘stress’’ and
trauma to the patient. McGee et al44 showed the immunomodu-
latory effects of N.O.T.E.S in an animal model, by demonstrating
consistently low TNF-alpha in the late post operative method in the
N.O.T.E.S cohort vs. the laparoscopy and laparotomy group.
Immunological beneﬁts of N.O.T.E.S is an area that is presently still
being evaluated and further research is necessary before these
claims can be proved.
This hypothesised ‘‘beneﬁcial’’ physiological response of
N.O.T.E.S may beneﬁt morbidly obese patients who are at a high
anaesthetic risk for operative procedures. Even laparoscopic
procedures are not devoid of complications in this cohort, espe-
cially problems related to wounds (hernia, infection etc) and to the
operative procedure itself. Decarli et al40 showed the beneﬁts of
transvaginal cholecystectomy in an obese patient, with an early
post operative discharge and minimal post operative analgesia.
Sleeve gastrectomy which is one of the types of bariatric surgery in
humans, was successfully performed in a porcine model by Mintz
et al.31 If the desired outcomes and instrumentation for N.O.T.E.S
are achieved, this can pave the way for bariatric surgeries in obese
patients. ASA grading and the anaesthetic risk will dictate
a patient’s procedural choice, but further research is required to
determine the anaesthetic requirements in N.O.T.E.S compared to
laparoscopic procedures.45
The other set of patients where N.O.T.E.S can be beneﬁcial is ITU
(Intensive Therapy Unit) patients, especially those with PEG gas-
trotomies where N.O.T.E.S could be employed for lumenal and peri-
toneal investigations without having the need to make another
gastrotomy.5,56 It may also beneﬁt in scenarioswhere conditions like
ischemic bowel, ischemic colitis etc which are difﬁcult to be diag-
nosed radiologically, can be diagnosed using N.O.T.E.S27 with
minimal complications, and less stress response compared to lapa-
roscopy. If reliable closure devices do become a reality, they could be
even modiﬁed to treat colonic perforations (colonoscopy related) or
dislodged gastrotomy tubes. Though these two groups of patients
may be the possible beneﬁciaries of N.O.T.E.S, it is still a long way
before it can be proven to be so.
5. Challenges and pitfalls
As with any new technique, there is still much to be learned
about this new approach to abdominal surgery. To date, the
majority of published reports on N.O.T.E.S have been on animal
models, and whether these studies can be transpolated to humanmodels is questionable. Moreover, many of these have been small
group animal studies rather than randomised trials to ascertain the
beneﬁts of N.O.T.E.S over laparoscopic surgery.37
Questions still remain about the ideal peritoneal access, with the
transvaginal route being described as the safest, but this can be
used in only half the population. Both animal studies and human
trials have shown reliable intraperitoneal exposure, but many of
these were virgin abdomens.9,13 The white paper published by
Natural Oriﬁce Surgery Consortium for Assessment and Research
(NOSCAR) in February 2006 emphasized zero tolerance for
complications that are unique to the N.O.T.E.S methodology.38 The
biggest obstacle as perceived by NOSCAR and the literature is the
ability to achieve 100% closure of the lumenal (gastric/colonic/
vaginal) puncture site, along with developing an acceptable
suturing and anastomotic device. The risk of infection can still be
a barrier to N.O.T.E.S, and human trials have shown these risks.
Palanivelu42 published case series of transvaginal cholecystecto-
mies, where the complication rates were 16% with one case of
subhepatic collection. The risk of infection and potential leak from
the closure sites still remains unanswered, as long term beneﬁts are
still to be proved.
Other challenges include spatial orientation where an endo-
scope in a retroﬂexed position may cause upside images and an
off-axis manipulation may be required.38 The problems with
insufﬂation and intra abdominal monitoring are still not addressed
convincingly in animal models,26 thus exposing physiologic
untoward events related to the pneumoperitoneum and bowel
distension (through air leaking into the bowel).38 Kavic et al39 have
summarised the steep learning curve encountered with the intro-
duction of N.O.T.E.S in a general surgical residency programme,
along with highlighting the need for a multidisciplinary approach.
This places emphasis on training vs. service delivery issues if
N.O.T.E.S reaches human trials. The challenges and complications
related to N.O.T.E.S are summarised in Table 3.6. Discussion
The interest and enthusiasm in the development of N.O.T.E.S can
be demonstrated by the increasing number of publications in this
ﬁeld. Compared to 1 publication in 2003 and 14 in 2004, in 2006
and 2007, 35 and 25 publications respectively were published.24
With the majority of research work in N.O.T.E.S originating from
USA and more recently from Europe, standardisation of evidence
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future development. At the Society of American Gastrointestinal
and Endoscopic Surgeons (SAGES) in 2005, it was felt that N.O.T.E.S
has transgressed the boundaries of traditional disciplines such as
endoscopy and laparoscopic surgery, and hence led to the estab-
lishment of NOSCAR (Natural Oriﬁce Surgery Consortium for
Assessment and Research), whose aim was to conduct and coor-
dinate research in this ﬁeld along with guiding the responsible
development of N.O.T.E.S.11 Following the lead, the European
counterparts formed the EURO-N.O.T.E.S, which was formed by the
ESGE (European Society for Gastrointestinal Endoscopy) and the
EAES (European Association for Endoscopic Surgery), and led to
development of research groups across France, Germany and
Belgium.24 In UK, the ALS (Association of Laparoscopic Surgeons) is
yet to publish a white paper on N.O.T.E.S, and as N.O.T.E.S is not
performed in the UK, there is no NICE guidance in this regard. At
present, an institutional review board (IRB) protocol is essential for
a N.O.T.E.S procedure to be performed to ensure patient protection
and safety.
N.O.T.E.S has demonstrated that most of the general and laparo-
scopic surgical procedures (Table 1) could be feasibly carried out in
animalmodels, but thedrawback is that theywere small animal study
groups with only porcine and swine models. Fritscher-Ravens et al37
published results from a randomised comparison of open surgical
access vs. N.O.T.E.S in pigs to determine the parameters predicting
complications after N.O.T.E.S. In this study, they showed that animal
behavior could be a reliable indicator of severe complications, while
fever, bodyweight, and the results of invitro culturesof theperitoneal
ﬂuid did not indicate complications. Whether these predictors hold
good for humans as well, needs to be seen.
The question of whether gastroenterologists with their endo-
scopic skills or surgeons with their laparoscopic skills are better
suited to practice N.O.T.E.S still needs to be addressed and evalu-
ated. N.O.T.E.S presents a steep learning curve with training and
stimulator models being difﬁcult to standardise. As summarised by
Palanivelu et al, even experienced laparoscopic surgeons found it
difﬁcult to practice N.O.T.E.S in all patients, as is evident by their
success to do transvaginal appendicectomy in only one out of six
patients, the rest being assisted by laparoscopy.14 Further research
and development into endoscopic instruments, along with reliable
closure devices for a gastrointestinal lumenal approach, will
accelerate the implementation of N.O.T.E.S in human models.
Though N.O.T.E.S is still being developed and trialed, other
alternatives using hybrid approaches such as natural oriﬁce tran-
sumbilical surgery (NOTUS) have shown promise. Nguyen et al46,47
have shown success at performing sleeve gastrectomy and chole-
cystectomy in human model using NOTUS. Palanivelu15 and
Zornig48 have shown hybrid approach success in cholecystecto-
mies, while the combination of miniature surgical robots53 and/or
transabdominal magnet devices with ﬂexible endoscopic instru-
ments is a rapidly developing modiﬁcation with promising
perspectives.49 Whether these procedures compete against or
complement N.O.T.E.S in the future needs to be seen.
With patient choice taking precedence in the western world,
N.O.T.E.Smaybe the cosmetic surgery of the future.Hence, theremay
be pressure on the surgeons to develop this technique which has
a steep learning curve. N.O.T.E.S has a futurewhich is engulfed in the
mist of unknown outcomes; only time will serve as the best judge.
7. Conclusion
N.O.T.E.S has the potential to be beneﬁcial in human pop-
ulations, especially in the ITU setting and morbidly obese patients.
Patient selection and indications remain to be deﬁned, along with
long term outcomes from the initial human trials. Though porcinemodels have shown encouraging outcomes, larger study groups
with longer outcomes need to be rigorously trialed before drawing
conclusions. Image stability and instrument preciseness in combi-
nation is a single limiting factor to overcome before the safe
implementation of N.O.T.E.S in humans is feasible. This has been
one of themain priorities of current N.O.T.E.S research. Randomised
trials among animalmodels, alongwith staggered and standardised
evidence based implementation in human models may be the way
forward for N.O.T.E.S.
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